Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017
Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Mutual impact of HIV infection on HIV/tuberculosis co-infection Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Predictors of death in patients with MDR-TB and HIV Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Immunologic recovery in HIV/TB co-infected patients after anti-TB treatment Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020
Treatment effectiveness and predictors of poor outcome in MDR-TB and XDR-TB Source: Breathe 2008; 6: 161 Year: 2009
Impact of HIV status, CD4 count and antiretroviral treatment on tuberculosis treatment outcomes in a low-burden country Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Bedaquiline in the treatment of patients with co-infection HIV/tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015
MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Medical care, treatment and support with co-infection TB/HIV in an infavorable region Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
TB situation in Bulgaria – epidemiology, TB-HIV co-infection Source: Eur Respir J 2006; 28: Suppl. 50, 16s Year: 2006
The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Impact of adverse drug reactions on treatment interruption in TB patients with and without HIV coinfection Source: ISSN=ISSN 1810-6838, ISBN=, page=190 Year: 2006
Poor treatment outcomes of XDR-TB patients in resource-limited settings Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
The twin epidemics: HIV / DR-TB co-infection in 2012 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015